M. Sassi

799 total citations
9 papers, 529 citations indexed

About

M. Sassi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Sassi has authored 9 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in M. Sassi's work include Lung Cancer Treatments and Mutations (3 papers), Neutropenia and Cancer Infections (2 papers) and Lung Cancer Research Studies (2 papers). M. Sassi is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Neutropenia and Cancer Infections (2 papers) and Lung Cancer Research Studies (2 papers). M. Sassi collaborates with scholars based in Italy. M. Sassi's co-authors include Maurizio Tonato, Alessandra Ravaioli, M. Marangolo, Filippo de Marinis, Cesare Gridelli, Roberto Bianco, A Masotti, Giorgio V. Scagliotti, Sandro Barni and Giorgio Cruciani and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

M. Sassi

9 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Sassi Italy	7	361	345	78	68	65	9	529
JN Atkins United States	11	303 0.8×	200 0.6×	143 1.8×	50 0.7×	117 1.8×	22	500
Lee Schwartzberg United States	8	333 0.9×	133 0.4×	92 1.2×	77 1.1×	113 1.7×	17	603
Maria Donatella Magri Italy	14	284 0.8×	150 0.4×	118 1.5×	149 2.2×	119 1.8×	44	564
E.W. Muller Netherlands	12	397 1.1×	133 0.4×	48 0.6×	38 0.6×	163 2.5×	19	547
Vittorio Franciosi Italy	17	533 1.5×	470 1.4×	131 1.7×	39 0.6×	160 2.5×	37	809
A. Oltra Spain	11	237 0.7×	116 0.3×	83 1.1×	35 0.5×	37 0.6×	18	394
Burton Needles United States	10	330 0.9×	104 0.3×	48 0.6×	29 0.4×	41 0.6×	17	544
Arzu Yaren Türkiye	14	283 0.8×	138 0.4×	82 1.1×	35 0.5×	137 2.1×	51	550
Molly Gabel United States	11	265 0.7×	97 0.3×	143 1.8×	56 0.8×	45 0.7×	17	480
Gina Villani United States	10	214 0.6×	133 0.4×	53 0.7×	37 0.5×	67 1.0×	24	456

Countries citing papers authored by M. Sassi

Since Specialization

Citations

This map shows the geographic impact of M. Sassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sassi more than expected).

Fields of papers citing papers by M. Sassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sassi. The network helps show where M. Sassi may publish in the future.

Co-authorship network of co-authors of M. Sassi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sassi. A scholar is included among the top collaborators of M. Sassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sassi. M. Sassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Boni, C., Giancarlo Bisagni, Luisa Savoldi, et al.. (2000). Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc). International Journal of Cancer. 87(5). 724–727. 6 indexed citations

Crinò, Lucio, Giorgio V. Scagliotti, Serafino Ricci, et al.. (1999). Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project. Journal of Clinical Oncology. 17(11). 3522–3530. 302 indexed citations

Boni, C., Luisa Savoldi, Giancarlo Bisagni, et al.. (1998). Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC). European Journal of Cancer. 34(12). 1974–1976. 2 indexed citations

Boccardo, Francesco, A. Rubagotti, D. Amoroso, et al.. (1998). Italian Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group Trials. Recent results in cancer research. 152. 453–470. 6 indexed citations

Bisagni, Giancarlo, C. Boni, Gabriella Moretti, et al.. (1998). Ifosfamide Bolus Followed by Five Days Continuous Infusion in Extensively Pretreated Patients with Advanced Breast Cancer: A Phase II Study. Tumori Journal. 84(6). 659–661. 3 indexed citations

Boni, C., Gabriella Moretti, Luisa Savoldi, et al.. (1996). Neoadjuvant Chemotherapy with Continuous Infusion of Cisplatin and Fluorouracil in Stage II-IV, M0 Squamous Cell Carcinoma of the Head and Neck. Tumori Journal. 82(6). 567–572. 6 indexed citations

Boccardo, Francesco, A. Rubagotti, Allison Perrotta, et al.. (1994). Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study. Annals of Oncology. 5(4). 337–342. 92 indexed citations

Roila, Fausto, C. Basurto, Sergio Bracarda, et al.. (1991). Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis. European Journal of Cancer and Clinical Oncology. 27(2). 119–121. 16 indexed citations

Roila, F., Marco Lupattelli, M. Sassi, et al.. (1991). Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Annals of Oncology. 2(6). 437–439. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact